| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPQTL2
|
Circulating adiponectin QTL on chromosome 5
|
|
ADM
|
adrenomedullin
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO3
|
argonaute RISC catalytic component 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHCY
|
adenosylhomocysteinase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALB
|
albumin
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMELX
|
amelogenin, X-linked
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARSG
|
arylsulfatase G
|
|
ARX
|
aristaless related homeobox
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASIP
|
agouti signaling protein
|
|
ASPN
|
asporin
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATN1
|
atrophin 1
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
|
|
ATXN7
|
ataxin 7
|
|
AVP
|
arginine vasopressin
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA3
|
carbonic anhydrase III
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALB2
|
calbindin 2
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPN7
|
calpain 7
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND2
|
cyclin D2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD28
|
CD28 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD68
|
CD68 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDA
|
cytidine deaminase
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKB
|
choline kinase beta
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CLU
|
clusterin
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COBLL1
|
cordon-bleu WH2 repeat protein-like 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COLEC10
|
collectin sub-family member 10 (C-type lectin)
|
|
COLEC11
|
collectin sub-family member 11
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSK
|
c-src tyrosine kinase
|
|
CST3
|
cystatin C
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTGF
|
connective tissue growth factor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DST
|
dystonin
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
EMP1
|
epithelial membrane protein 1
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP400
|
E1A binding protein p400
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETF1
|
eukaryotic translation termination factor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
FADS2
|
fatty acid desaturase 2
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGG
|
fibrinogen gamma chain
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
GATA3
|
GATA binding protein 3
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIMAP5
|
GTPase, IMAP family member 5
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLS
|
glutaminase
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK1
|
hexokinase 1
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HOXA9
|
homeobox A9
|
|
HOXC8
|
homeobox C8
|
|
HP
|
haptoglobin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH3B
|
isocitrate dehydrogenase 3 (NAD+) beta
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL11
|
interleukin 11
|
|
IL13
|
interleukin 13
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IP6K1
|
inositol hexakisphosphate kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JTB
|
jumping translocation breakpoint
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIF1B
|
kinesin family member 1B
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT18
|
keratin 18, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPC
|
lipase, hepatic
|
|
LMF1
|
lipase maturation factor 1
|
|
LMNA
|
lamin A/C
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPLAL1
|
lysophospholipase-like 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAGEA2
|
melanoma antigen family A2
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAP7
|
microtubule-associated protein 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAT1A
|
methionine adenosyltransferase I, alpha
|
|
MB
|
myoglobin
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME2
|
malic enzyme 2, NAD(+)-dependent, mitochondrial
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MGP
|
matrix Gla protein
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIR107
|
microRNA 107
|
|
MIR10B
|
microRNA 10b
|
|
MIR126
|
microRNA 126
|
|
MIR17
|
microRNA 17
|
|
MIR203A
|
microRNA 203a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR212
|
microRNA 212
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR30E
|
microRNA 30e
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRC1
|
mannose receptor, C type 1
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO5C
|
myosin VC
|
|
MYO7A
|
myosin VIIA
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NIP7
|
NIP7, nucleolar pre-rRNA processing protein
|
|
NME8
|
NME/NM23 family member 8
|
|
NMRAL1
|
NmrA-like family domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRG1
|
neuregulin 1
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUDT15
|
nudix (nucleoside diphosphate linked moiety X)-type motif 15
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN3
|
opsin 3
|
|
OSM
|
oncostatin M
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PFN1
|
profilin 1
|
|
PGA3
|
pepsinogen 3, group I (pepsinogen A)
|
|
PGC
|
progastricsin (pepsinogen C)
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIGC
|
phosphatidylinositol glycan anchor biosynthesis, class C
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAC4
|
placenta-specific 4
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLIN1
|
perilipin 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
PON3
|
paraoxonase 3
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRSS8
|
protease, serine, 8
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RHO
|
rhodopsin
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RS1
|
retinoschisin 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100B
|
S100 calcium binding protein B
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB3A2
|
secretoglobin, family 3A, member 2
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCT
|
secretin
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIAE
|
sialic acid acetylesterase
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A7
|
solute carrier family 5 (sodium/choline cotransporter), member 7
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLFN12
|
schlafen family member 12
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD5
|
SMAD family member 5
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMS
|
spermine synthase
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRPE
|
small nuclear ribonucleoprotein polypeptide E
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOST
|
sclerostin
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPAST
|
spastin
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAB1
|
stabilin 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STIM1
|
stromal interaction molecule 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC3
|
tachykinin 3
|
|
TACR3
|
tachykinin receptor 3
|
|
TADA1
|
transcriptional adaptor 1
|
|
TBX15
|
T-box 15
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TF
|
transferrin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFPT
|
TCF3 (E2A) fusion partner (in childhood Leukemia)
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRIAP1
|
TP53 regulated inhibitor of apoptosis 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSC1
|
tuberous sclerosis 1
|
|
TTR
|
transthyretin
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
UCN3
|
urocortin 3
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UHRF1BP1
|
UHRF1 binding protein 1
|
|
UMPS
|
uridine monophosphate synthetase
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WARS
|
tryptophanyl-tRNA synthetase
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
|
ZNRF3
|
zinc and ring finger 3
|
|
ZPR1
|
ZPR1 zinc finger
|
